2018
DOI: 10.23853/bsehm.2018.0601
|View full text |Cite
|
Sign up to set email alerts
|

Potential role of hydrogen sulfide in osteoarthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Pathological conditions associated with so-called “H 2 S-poor” disease states—and amenable to correction by H 2 S donors—include ( 243 , 295 ) aging, ischemia, cardiac hypertrophy, heart failure (HF), liver disease (cirrhosis, steatosis), hypertension, atherosclerosis, endothelial dysfunction, diabetic complications, preeclampsia, Alzheimer's disease (AD), and Huntington's disease (HD). Further, Szabo and Papapetropoulos rightly point out that not only H 2 S-poor diseases can be corrected by H 2 S supplementation, since “there are also several indications where endogenous H 2 S levels are not suppressed, and yet H 2 S donation may be beneficial or warranted.” Additional evidence, obtained mainly after the list just cited was compiled, supports considering therapeutic application of H 2 S prodrugs in cancer ( 148 ), psoriasis ( 12 ), multiple viral infections ( 24 , 25 ), colitis ( 180 ), autoimmune pathologies ( 42 ), systemic sclerosis ( 2 ), multiple sclerosis ( 245 ), Parkinson's disease (PD) ( 111 ), intracerebral hemorrhage ( 288 ), Duchenne muscular dystrophy/cardiomyopathy ( 44 ), allergic diseases ( 173 ), fibrotic disorders ( 229 ), osteoarthritis ( 164 ), osteoporosis ( 281 ), sarcopenia ( 32 ), pulmonary hypertension ( 287 ), ocular hypertension ( 225 ), kidney diseases ( 15 ), hearing loss ( 152 ), lens opacification ( 190 ), testicular dysfunction ( 262 ), male subfertility ( 178 ), erectile dysfunction ( 64 ), and periodontitis ( 89 ) as well.…”
Section: Prodrug-based H 2 S Supplementation Is a mentioning
confidence: 99%
“…Pathological conditions associated with so-called “H 2 S-poor” disease states—and amenable to correction by H 2 S donors—include ( 243 , 295 ) aging, ischemia, cardiac hypertrophy, heart failure (HF), liver disease (cirrhosis, steatosis), hypertension, atherosclerosis, endothelial dysfunction, diabetic complications, preeclampsia, Alzheimer's disease (AD), and Huntington's disease (HD). Further, Szabo and Papapetropoulos rightly point out that not only H 2 S-poor diseases can be corrected by H 2 S supplementation, since “there are also several indications where endogenous H 2 S levels are not suppressed, and yet H 2 S donation may be beneficial or warranted.” Additional evidence, obtained mainly after the list just cited was compiled, supports considering therapeutic application of H 2 S prodrugs in cancer ( 148 ), psoriasis ( 12 ), multiple viral infections ( 24 , 25 ), colitis ( 180 ), autoimmune pathologies ( 42 ), systemic sclerosis ( 2 ), multiple sclerosis ( 245 ), Parkinson's disease (PD) ( 111 ), intracerebral hemorrhage ( 288 ), Duchenne muscular dystrophy/cardiomyopathy ( 44 ), allergic diseases ( 173 ), fibrotic disorders ( 229 ), osteoarthritis ( 164 ), osteoporosis ( 281 ), sarcopenia ( 32 ), pulmonary hypertension ( 287 ), ocular hypertension ( 225 ), kidney diseases ( 15 ), hearing loss ( 152 ), lens opacification ( 190 ), testicular dysfunction ( 262 ), male subfertility ( 178 ), erectile dysfunction ( 64 ), and periodontitis ( 89 ) as well.…”
Section: Prodrug-based H 2 S Supplementation Is a mentioning
confidence: 99%